Skip to main content

Centessa Pharmaceuticals plc

CNTADelisted Jun 24, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001847903

Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Centessa Pharmaceuticals plc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Centessa Pharmaceuticals plc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Centessa Pharmaceuticals plc
NameTitleLast reported holdingLast filingFilings, past year
Medicxi Growth I LP10% Owner0IndirectJun 24, 20261
Medicxi Growth Co-Invest I LP10% Owner0IndirectJun 24, 20261
Medicxi Ventures Management (Jersey) Ltd10% Owner0IndirectJun 24, 20261
Medicxi Growth I GP Ltd10% Owner0IndirectJun 24, 20261
Medicxi Ventures I GP Ltd10% Owner0IndirectJun 24, 20261
Medicxi Ventures I LP10% Owner0IndirectJun 24, 20261
Medicxi Co-Invest I LP10% Owner0IndirectJun 24, 20261
Medicxi Secondary I LP10% Owner0IndirectJun 24, 20261
Medicxi Secondary I GP Ltd.10% Owner0IndirectJun 24, 20261
Medicxi Secondary Co-Invest I LP10% Owner0IndirectJun 24, 20261
Index Ventures Life VI (Jersey) L.P.10% Owner0IndirectJun 24, 20261
Yucca (Jersey) SLP10% Owner0IndirectJun 24, 20261
Index Venture Life Associates VI Ltd10% Owner0IndirectJun 24, 20261
Hedley Mary LynneDirector–Jun 24, 20261
Zbar Brett I WDirector–Jun 24, 20261
Weinhoff Gregory MChief Business Officer0Jun 24, 20264
Crowley John JChief Financial Officer0Jun 24, 20262
De Rubertis FrancescoDirector0IndirectJun 24, 20261
Kanes StephenChief Medical Officer0Jun 24, 20262
Kulkarni SamarthDirector–Jun 24, 20261
Anderson Karen M.Chief People Officer0Jun 24, 20265
Goyal ArjunDirector0IndirectJun 24, 20261
Hussain Iqbal JChief Legal Officer0IndirectJun 24, 20264
Stuckley CarolDirector–Jun 24, 20261
Bush Tia LChief Technology & Quality Ofc0Jun 24, 20264
Hukkelhoven MathiasDirector–Jun 24, 20261
Deferiere RaphaelChief Accounting Officer0Jun 24, 20262
Accardi Mario AlbertoChief Executive Officer0Jun 24, 20267
Saha SaurabhChief Executive Officer221,017Jul 21, 20250
Chao David MChief Administrative Officer225,007Mar 19, 20250
Rotman HarrisSVP Regulatory Affairs62,625Feb 2, 20240
Grainger David JChief Innovation Officer962,790Jan 2, 20240
GAP (Bermuda) L.P.Director, 10% Owner–Jun 26, 20230
General Atlantic Genpar (Bermuda), L.P.Director, 10% Owner–Jun 26, 20230
General Atlantic Partners (Bermuda) EU, L.P.Director, 10% Owner–Jun 26, 20230
General Atlantic Partners (Bermuda) IV, L.P.Director, 10% Owner–Jun 26, 20230
General Atlantic Partners (Lux), SCSpDirector, 10% Owner–Jun 26, 20230
General Atlantic GenPar (Lux) SCSpDirector, 10% Owner–Jun 26, 20230
General Atlantic (Lux) S.a r.l.Director, 10% Owner–Jun 26, 20230
General Atlantic UM B.V.Director, 10% Owner–Jun 26, 20230
General Atlantic Cooperatief U.A.Director, 10% Owner–Jun 26, 20230
General Atlantic Cooperatief, L.P.Director, 10% Owner–Jun 26, 20230
Yver AntoineEVP & Chairman of Development783,066Jun 2, 20230
Templeman ThomasChief Technology Officer188,244Apr 4, 20230
Shahidi JavadChief Medical Officer165,000Nov 23, 20220
Thorell MarellaChief Accounting Officer53,101Mar 23, 20220
Kantoff AaronDirector60,000Nov 18, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 24, 2026 (view filing)4:26 PM ETJun 24Same dayMedicxi Growth I LP and 9 others10% OwnerSSale−20.0M––−100.0%0 after6 lots
Jun 24, 2026 (view filing)4:23 PM ETJun 24Same dayIndex Ventures Life VI (Jersey) L.P. and 2 others10% OwnerSSale−9.96M––−100.0%0 after2 lots
Mar 27, 2026 (view filing)Mar 261 dayAnderson Karen M.Chief People OfficerSSale−41.1K$30.12−$1.24M−39.8%62.1K after10b5-1
Mar 26, 2026 (view filing)Mar 26Same dayWeinhoff Gregory MChief Business OfficerSSale−24.0K$30.00−$719.9K−26.7%65.9K after10b5-1
Mar 18, 2026 (view filing)Mar 16-172 daysAnderson Karen M.Chief People OfficerSSale−74.8K$28.20−$2.11M−54.6%62.1K after2 lots10b5-1
Mar 16, 2026 (view filing)Mar 133 daysAnderson Karen M.Chief People OfficerSSale−120.0K$26.25−$3.15M−65.9%62.1K afterAmended2 lots10b5-1
Mar 13, 2026 (view filing)Mar 13Same dayWeinhoff Gregory MChief Business OfficerSSale−73.2K$26.33−$1.93M−52.6%65.9K after2 lots10b5-1
Feb 3, 2026 (view filing)Jan 30-Feb 24 daysHussain Iqbal JChief Legal OfficerSSale−40.0K$25.15−$1.00M−40.9%57.6K after2 lots
Dec 9, 2025 (view filing)Dec 9Same dayAccardi Mario AlbertoPresident, Orexin ProgramSSale−10.0K$28.83−$288.3K−5.3%178.8K after2 lots10b5-1
Dec 8, 2025 (view filing)Dec 8Same dayAccardi Mario AlbertoPresident, Orexin ProgramSSale−10.0K$30.00−$300.0K−5.0%188.8K after10b5-1
Nov 18, 2025 (view filing)Nov 171 dayHussain Iqbal JGeneral CounselSSale−6.00K$27.64−$165.8K−5.4%105.4K after10b5-1
Nov 18, 2025 (view filing)Nov 171 dayBush Tia LChief Technology & Quality OfcSSale−40.0K$28.00−$1.12M−24.8%121.5K after10b5-1
Nov 13, 2025 (view filing)Nov 121 dayBush Tia LChief Technology & Quality OfcSSale−40.0K$26.00−$1.04M−24.8%121.5K after10b5-1
Oct 27, 2025 (view filing)Oct 27Same dayAccardi Mario AlbertoPresident, Orexin ProgramSSale−8.00K$25.00−$200.0K−4.0%194.4K after10b5-1
Oct 16, 2025 (view filing)Oct 151 dayHussain Iqbal JGeneral CounselSSale−6.00K$22.41−$134.5K−5.4%105.4K after10b5-1
Sep 24, 2025 (view filing)Sep 24Same dayBush Tia LChief Technology & Quality OfcSSale−35.0K$24.00−$840.0K−22.4%121.5K after10b5-1
Sep 16, 2025 (view filing)Sep 16Same dayAccardi Mario AlbertoPresident, Orexin ProgramSSale−8.17K$21.39−$174.8K−4.0%197.4K after2 lots10b5-1
Sep 15, 2025 (view filing)Sep 15Same dayHussain Iqbal JGeneral CounselSSale−6.00K$21.85−$131.1K−5.4%105.4K after10b5-1
Sep 11, 2025 (view filing)Sep 9-102 daysBush Tia LChief Technology & Quality OfcSSale−49.8K$21.00−$1.05M−29.1%121.5K after2 lots10b5-1
Sep 11, 2025 (view filing)Sep 9-102 daysHussain Iqbal JGeneral CounselSSale−40.0K$21.01−$840.2K−27.5%105.4K after2 lots10b5-1
Sep 11, 2025 (view filing)Sep 92 daysAccardi Mario AlbertoPresident, Orexin ProgramSSale−7.00K$20.00−$140.0K−3.3%205.6K after10b5-1
Aug 15, 2025 (view filing)Aug 15Same dayHussain Iqbal JGeneral CounselSSale−6.00K$17.23−$103.4K−5.4%105.4K after10b5-1
Jul 30, 2025 (view filing)Jul 291 dayAccardi Mario AlbertoPresident, Orexin ProgramSSale−8.32K$15.23−$126.7K−3.8%208.2K after10b5-1
Jul 25, 2025 (view filing)Jul 25Same dayWeinhoff Gregory MChief Business OfficerSSale−10.0K$15.56−$155.6K−7.6%122.3K after10b5-1
Jul 21, 2025 (view filing)Jul 21Same daySaha SaurabhChief Executive OfficerSSale−55.0K$15.92−$875.6K−19.9%221.0K after10b5-1
Jul 17, 2025 (view filing)Jul 152 daysHussain Iqbal JGeneral CounselSSale−6.00K$14.93−$89.6K−5.4%105.4K after10b5-1
Jun 25, 2025 (view filing)Jun 25Same dayWeinhoff Gregory MChief Business OfficerSSale−10.0K$13.86−$138.6K−7.6%122.3K after10b5-1
Jun 25, 2025 (view filing)Jun 241 dayHussain Iqbal JGeneral CounselSSale−12.0K$14.02−$168.2K−10.2%105.4K after10b5-1
Jun 25, 2025 (view filing)Jun 241 dayAccardi Mario AlbertoPresident, Orexin ProgramSSale−15.0K$14.00−$210.0K−6.5%216.5K after10b5-1
Jun 20, 2025 (view filing)Jun 20Same daySaha SaurabhChief Executive OfficerSSale−55.0K$12.63−$694.6K−19.9%221.0K after10b5-1
May 27, 2025 (view filing)May 27Same dayWeinhoff Gregory MChief Business OfficerSSale−10.0K$12.82−$128.2K−7.6%122.3K after10b5-1
May 20, 2025 (view filing)May 20Same daySaha SaurabhChief Executive OfficerSSale−55.0K$12.71−$699.0K−19.9%221.0K after10b5-1
May 19, 2025 (view filing)May 15-164 daysGoyal ArjunDirectorPPurchase+462.6K$12.68+$5.87MNew position462.6K after2 lots
May 2, 2025 (view filing)May 11 dayHussain Iqbal JGeneral CounselSSale−311$14.00−$4.35K−0.3%105.4K after10b5-1
Apr 29, 2025 (view filing)Apr 25-284 daysHussain Iqbal JGeneral CounselSSale−5.69K$14.00−$79.7K−5.1%105.4K after2 lots10b5-1
Apr 25, 2025 (view filing)Apr 25Same dayWeinhoff Gregory MChief Business OfficerSSale−11.7K$13.61−$159.8K−8.8%122.3K after10b5-1
Apr 22, 2025 (view filing)Apr 21-221 daySaha SaurabhChief Executive OfficerSSale−55.0K$12.39−$681.6K−19.9%221.0K after2 lots10b5-1
Mar 26, 2025 (view filing)Mar 251 dayWeinhoff Gregory MChief Business OfficerSSale−10.0K$16.34−$163.4K−6.9%134.0K after10b5-1
Mar 21, 2025 (view filing)Mar 201 daySaha SaurabhChief Executive OfficerSSale−55.0K$16.69−$918.0K−16.6%276.0K after10b5-1
Mar 19, 2025 (view filing)Mar 172 daysChao David MChief Administrative OfficerSSale−7.00K$17.17−$120.2K−3.0%225.0K after2 lots10b5-1
Mar 19, 2025 (view filing)Mar 172 daysHussain Iqbal JGeneral CounselSSale−6.00K$16.45−$98.7K−5.4%105.4K after10b5-1
Feb 26, 2025 (view filing)Feb 251 dayWeinhoff Gregory MChief Business OfficerSSale−11.5K$15.25−$175.3K−7.9%134.0K after10b5-1
Feb 20, 2025 (view filing)Feb 20Same daySaha SaurabhChief Executive OfficerSSale−55.0K$15.93−$876.1K−14.2%331.0K after2 lots10b5-1
Feb 19, 2025 (view filing)Feb 181 dayHussain Iqbal JGeneral CounselSSale−6.00K$16.17−$97.0K−5.4%105.4K after2 lots10b5-1
Feb 10, 2025 (view filing)Feb 7-103 daysAnderson Karen M.Chief People OfficerSSale−31.0K$19.03−$589.1K−36.3%54.3K after2 lots10b5-1
Feb 4, 2025 (view filing)Feb 31 dayAnderson Karen M.Chief People OfficerSSale−6.47K$16.86−$109.1K−10.6%54.3K after10b5-1
Feb 4, 2025 (view filing)Feb 31 dayBush Tia LChief Technology & Quality OfcSSale−11.0K$16.86−$185.5K−8.3%121.5K after10b5-1
Jan 28, 2025 (view filing)Jan 271 dayWeinhoff Gregory MChief Business OfficerSSale−11.7K$16.47−$193.4K−6.8%159.8K after10b5-1
Jan 22, 2025 (view filing)Jan 211 daySaha SaurabhChief Executive OfficerSSale−55.0K$15.77−$867.5K−11.4%429.4K after2 lots10b5-1
Jan 17, 2025 (view filing)Jan 152 daysHussain Iqbal JGeneral CounselSSale−6.00K$15.29−$91.7K−4.8%118.3K after10b5-1